Table 2: The prevalence of HTLV1 antibodies in studied subjects according to the age distribution of women and their gestational age.

HTLV1 antibodyNegativePositiveTotalP value
No (%)No (%)No (%)

Maternal age
 <21 years old68 (17.0%)0 (0.00%)68 (16.7%)
 21–30 years old248 (61.8%)6 (100.0%)254 (62.4%)0.783
 >30 years old85 (21.2%)0 (.0%)85 (20.9%)

Total401 (100.0%)6 (100.0%)407 (100.0%)

Gestational age
 Before term23 (5.8%)0 (.0%)23 (5.8%)
 Term347 (86.5%)6 (100.0%)353 (86.7%)0.271
 After term31 (7.7%)0 (0%)31 (7.6%)

Total401 (100.0%)6 (100.0%)407 (100.0%)